Ventricular Septal Rupture Secondary to Myocardial Infarction Post Fibrinolytic Therapy: A Case Report

A Case Report

  • Ankitha peetha Nirmala College Of Pharmacy, Mangalagiri-522503, Guntur, Andhra Pradesh, India http://orcid.org/0000-0002-8924-9560
  • Nahida Farheen Shaik Nirmala college of pharmacy
  • Spandana Ayela Nirmala college of pharmacy
Keywords: Myocardial infarction, Ventricular septal rupture, fibrinolytic therapy

Abstract

Myocardial infarction can be complicated by Ventricular septal rupture which is a rare fatal grim mechanical complication of MI which is a surgical emergency due to its incredibly high mortality rate. We depict a case of Anterior wall MI which was complicated by Ventricular septal rupture post fibrinolytic therapy.

Author Biographies

Ankitha peetha, Nirmala College Of Pharmacy, Mangalagiri-522503, Guntur, Andhra Pradesh, India
Doctor of Pharmacy Intern, Department of Pharmacy Practice, Nirmala College Of Pharmacy, Mangalagiri-522503, Guntur, Andhra Pradesh, India
Nahida Farheen Shaik, Nirmala college of pharmacy
Doctor of Pharmacy Intern, Department of pharmacy practice Nirmala college of pharmacy, Mangalagiri-522503, Guntur, Andhra Pradesh, India
Spandana Ayela, Nirmala college of pharmacy
Doctor of Pharmacy Internee, department of pharmacy practice, Nirmala College Of Pharmacy, Mangalagiri-522503, Guntur, Andhra Pradesh, India

References

1. Brandon M. ,Jones Samir R., Kapadia Nicholas G. ,Smedira Michael RobichE., Murat Tuzcu Venu Menon Amar Krishnaswamy Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. European Heart Journal, Volume 35, Issue 31, 14 August 2014 Pages 2060–2068.
2. Shabir Bhimji, Postinfarction Ventricular Septal Rupture Treatment & Management.Medscape Mar 09, 2017
3. Anna Ledakowicz-Polak, Sławomir Jander, Michał Kidawa, Karolina Stokfisz and Marzenna Zielińska .Ventricular Septal Rupture After Acute Myocardial Infarction-Do We Know Which Strategy to Choose? Clin Exp Cardiolog May 20, 2017 8:522. doi: 10.4172/2155-9880.1000522.
4. Honan MB, Harrell FE, Reimer KA, Califf RM, Mark DB, Pryor DB, Hlatky MA. Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. J Am Coll Cardiol.1990; 16:359–367.
5. Crenshaw BS, Granger CB, Birnbaum Y, Pieper KS, Morris DC, Kleiman NS, Vahanian A. et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation. 2000;101(1):27–32. doi: 10.1161/01.CIR.101.1.27.
6. Becker RC, Hochman JS, Cannon CP, et al. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study. J Am Coll Cardiol 1999;33:479–87.
7. Crenshaw BS, Granger CB, Birnbaum Y, Pieper KS, Morris DC, Kleiman NS, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries ) trial investigators. Circulation. 2000;101:27-32
8. James E. Lock, MD, Peter C. Block, MD, Raymond G. McKay, et al. Transcatheter Closure of Ventricular Septal Defects Circulation. 1988;78:361–368
Published
2019-08-31
How to Cite
1.
peetha A, Shaik N, Ayela S. Ventricular Septal Rupture Secondary to Myocardial Infarction Post Fibrinolytic Therapy: A Case Report. J Pharm Care. 7(1-2):37-38.
Section
Case Report(s)